Berk–Tabatznik syndrome
| Berk–Tabatznik syndrome | |
|---|---|
| Synonyms | Berk syndrome, Tabatznik syndrome |
| Pronounce | N/A |
| Specialty | Cardiology |
| Symptoms | Arrhythmia, palpitations, syncope |
| Complications | N/A |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history of the condition |
| Diagnosis | Electrocardiogram (ECG), genetic testing |
| Differential diagnosis | Long QT syndrome, Brugada syndrome |
| Prevention | N/A |
| Treatment | Beta blockers, antiarrhythmic drugs, implantable cardioverter-defibrillator (ICD) |
| Medication | N/A |
| Prognosis | Variable, depends on severity and treatment |
| Frequency | Rare |
| Deaths | N/A |
Berk–Tabatznik syndrome is a rare genetic disorder characterized by short stature, intellectual disability, and distinctive facial features. The syndrome was first described by Dr. Berk and Dr. Tabatznik in 1984.
Symptoms and Signs[edit]
The most common symptoms of Berk–Tabatznik syndrome include:
- Short stature
- Intellectual disability
- Distinctive facial features such as a broad forehead, deep-set eyes, and a small chin
- Other physical abnormalities may also be present
Causes[edit]
Berk–Tabatznik syndrome is a genetic disorder, which means it is caused by changes (mutations) in one or more genes. However, the specific genes involved in this syndrome are not yet known.
Diagnosis[edit]
Diagnosis of Berk–Tabatznik syndrome is based on the presence of characteristic clinical features. Genetic testing may also be used to confirm the diagnosis.
Treatment[edit]
There is currently no cure for Berk–Tabatznik syndrome. Treatment is supportive and based on the symptoms present in each individual.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
